Correlation Between Allarity Therapeutics and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Allarity Therapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Altamira Therapeutics.
Diversification Opportunities for Allarity Therapeutics and Altamira Therapeutics
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Allarity and Altamira is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Altamira Therapeutics
Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 0.74 times more return on investment than Altamira Therapeutics. However, Allarity Therapeutics is 1.35 times less risky than Altamira Therapeutics. It trades about -0.18 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 150.00 in Allarity Therapeutics on August 24, 2024 and sell it today you would lose (24.00) from holding Allarity Therapeutics or give up 16.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Allarity Therapeutics vs. Altamira Therapeutics
Performance |
Timeline |
Allarity Therapeutics |
Altamira Therapeutics |
Allarity Therapeutics and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Allarity Therapeutics and Altamira Therapeutics
The main advantage of trading using opposite Allarity Therapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |